PL345951A1 - Phagocytic assay method - Google Patents

Phagocytic assay method

Info

Publication number
PL345951A1
PL345951A1 PL99345951A PL34595199A PL345951A1 PL 345951 A1 PL345951 A1 PL 345951A1 PL 99345951 A PL99345951 A PL 99345951A PL 34595199 A PL34595199 A PL 34595199A PL 345951 A1 PL345951 A1 PL 345951A1
Authority
PL
Poland
Prior art keywords
assay method
phagocytic assay
phagocytic
assay
Prior art date
Application number
PL99345951A
Inventor
Elke Smits
Criekinge Wim Maria Rene Van
Thierry Andre Oliver E Bogaert
Original Assignee
Devgen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812660.0A external-priority patent/GB9812660D0/en
Priority claimed from GBGB9820816.8A external-priority patent/GB9820816D0/en
Application filed by Devgen Nv filed Critical Devgen Nv
Publication of PL345951A1 publication Critical patent/PL345951A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL99345951A 1998-06-11 1999-06-10 Phagocytic assay method PL345951A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812660.0A GB9812660D0 (en) 1998-06-11 1998-06-11 Engulfment gene and uses thereof
GBGB9820816.8A GB9820816D0 (en) 1998-09-24 1998-09-24 Engulfment gene and uses thereof

Publications (1)

Publication Number Publication Date
PL345951A1 true PL345951A1 (en) 2002-01-14

Family

ID=26313846

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345951A PL345951A1 (en) 1998-06-11 1999-06-10 Phagocytic assay method

Country Status (11)

Country Link
EP (1) EP1084242A2 (en)
JP (1) JP2002517238A (en)
KR (1) KR20010071453A (en)
CN (1) CN1305525A (en)
AU (1) AU4608499A (en)
BR (1) BR9911097A (en)
CA (1) CA2332993A1 (en)
HU (1) HUP0102349A2 (en)
IL (1) IL140016A0 (en)
PL (1) PL345951A1 (en)
WO (1) WO1999064586A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020004041A1 (en) * 1999-02-19 2002-01-10 Albert Matthew L. Methods for abrogating a cellular immune response
US6489535B1 (en) 1999-03-18 2002-12-03 The Board Of Trustees Of The Leland Stanford Junior University Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
US6316690B1 (en) 1999-08-04 2001-11-13 Tosk, Inc. Non-mammalian transgenic animal model for cellular proliferative diseases
US6365129B1 (en) 1999-08-04 2002-04-02 Tosk, Inc. Invivo high throughput toxicology screening method
US7615676B2 (en) 2001-11-30 2009-11-10 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
US7491810B2 (en) * 2001-11-30 2009-02-17 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
WO2018212612A1 (en) * 2017-05-17 2018-11-22 울산과학기술원 Method and device for evaluating immune cells using magnetic particle
KR102213080B1 (en) * 2017-05-17 2021-02-08 울산과학기술원 Method for evaluating immune cells using magnetic particles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232061B1 (en) * 1992-04-01 2001-05-15 Cambridge Neuroscience, Inc. Homology cloning

Also Published As

Publication number Publication date
WO1999064586A3 (en) 2000-04-27
EP1084242A2 (en) 2001-03-21
HUP0102349A2 (en) 2001-10-28
WO1999064586A2 (en) 1999-12-16
IL140016A0 (en) 2002-02-10
AU4608499A (en) 1999-12-30
BR9911097A (en) 2001-02-13
CN1305525A (en) 2001-07-25
KR20010071453A (en) 2001-07-28
CA2332993A1 (en) 1999-12-16
JP2002517238A (en) 2002-06-18

Similar Documents

Publication Publication Date Title
GB9809414D0 (en) Method
GB9809776D0 (en) Method
PL345951A1 (en) Phagocytic assay method
GB9814055D0 (en) Method
GB9810722D0 (en) Method
GB9819764D0 (en) Method
GB9802475D0 (en) Method
GB9819769D0 (en) Method
GB9817266D0 (en) Method
GB9905447D0 (en) Processes
GB9824321D0 (en) Method
GB9827585D0 (en) Assay method
GB9821225D0 (en) Method
GB9820185D0 (en) Method
GB9809782D0 (en) Method
GB9809780D0 (en) Method
GB9821038D0 (en) Method
GB9812772D0 (en) Assay method
GB9819945D0 (en) Assay method
GB9825374D0 (en) Method
GB9804355D0 (en) Method
GB9823963D0 (en) Method
GB9704374D0 (en) Assay method
GB9801888D0 (en) Panelling
GB9811088D0 (en) Method

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)